Baxter International Stock - Early tender results on 2026 and 2027 notes
18.06.2026 - 16:29:08 | ad-hoc-news.de
Edited by ad hoc news Chart & Technicals Desk. Verified prior to publication on 06/18/2026, 16:23 CET. Details in the imprint.
Baxter International (US0673431090) has disclosed early tender results for its 2.600% senior notes due 2026 and 1.915% senior notes due 2027. The liability-management step was announced in a Business Wire release this morning, as the group continues to refine its capital structure.
All news and analysis on Baxter International stock
Key figures, background and further reporting on Baxter International stock can be found in the dedicated topic area on ad-hoc-news.de.
What Baxter reported on its notes
According to a Business Wire release dated 06/17/2026, Baxter reported early tender results for its 2.600% senior notes due 2026 and 1.915% senior notes due 2027.
The company is pursuing this tender offer as part of ongoing balance-sheet management, against the backdrop of portfolio reshaping and the planned spin-off of its kidney-care business.
Thursday focus on the chart
Baxter International shares closed at $19.39 on 06/17/2026, down 5.2% on the day, according to GuruFocus data.
TradingKey shows the stock at $19.69 at the 06/17 close, with a beta of 0.65 and a risk assessment score of 6.65 within the healthcare equipment and supplies industry.
The product behind the stock
Baxter International generates most of its revenue from medical products such as intravenous (IV) solutions, infusion pumps and injectable drugs, alongside renal-care therapies and clinical nutrition offerings for hospitals and outpatient settings.
Where the stock trades today
Baxter International shares (US0673431090) trade on the New York Stock Exchange at $19.69 as of 06/17/2026, 16:00 ET.
Baxter International at a glance
- Company: Baxter International Inc.
- ISIN: US0673431090
- WKN: 853815
- Ticker: BAX
- Venue: NYSE
- Price (as of 06/17/2026, 16:00 ET): 19.69 USD
- Market cap: 10,000,000,000 USD (as of 06/17/2026)
- Sector / Industry: Health Care / Health Care Equipment & Supplies
- Index membership: S&P 500
- Next earnings date: not officially scheduled
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
